First elected: 4th July 2024
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
These initiatives were driven by Susan Murray, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Susan Murray has not been granted any Urgent Questions
Susan Murray has not been granted any Adjournment Debates
Susan Murray has not introduced any legislation before Parliament
Susan Murray has not co-sponsored any Bills in the current parliamentary sitting
The British Business Bank is undertaking a multi-year evaluation of the Covid-19 loan schemes, looking at whether the schemes met their objectives. The Year 2 evaluation report was published in November 2023 and shows that the schemes met their primary objectives of unlocking credit for businesses at scale and speed, reaching just over a quarter of small businesses in the UK. Evaluation evidence to date suggest that the schemes have had a positive impact on business outcomes like survival, turnover and employment.
Covid loan guarantee scheme performance data is published on a quarterly basis. As at 30 September 2024, within the Bounce Back Loan Scheme, £6.61 billion had been fully repaid by borrowers and £12.10 billion was being repaid on schedule.
The Consumer Rights Act 2015 sets out the standards consumers can expect when a trader supplies goods and services, including building work, and remedies if these rights are breached. Consumers can seek redress through local authority trading standards or the Small Claims Court.
Ensuring that we have a high-quality and professional construction industry is the best way to protect commercial clients. The Building Safety Act 2022 has introduced competence requirements for both individuals and businesses working in the built environment.
The Turing Scheme is the UK government’s global programme to provide grants for students to do study and work placements anywhere in the world, including in the EU. Students can develop new skills, gain international experience and boost their employability. Since its introduction following the UK’s departure from the Erasmus+ programme, the Turing Scheme has provided funding to support more than 160,000 international placements. In addition to travel and living costs, for students from disadvantaged backgrounds the Turing Scheme covers items that students may need to be able to travel, including vaccinations, visa applications, passports and insurance costs.
For the 2024/25 academic year, over £105 million has been allocated to send more than 43,000 students from across the UK on study and work placements around the world.
This government is committed to ending the VAT exemption that private schools enjoy. HM Treasury will deliver the tax changes and is engaging with a range of stakeholders as it carefully considers the impact of this policy.
Collection fees were introduced in 2014, with the objectives of subsidising the cost of the service; encouraging greater parental collaboration and more family-based arrangements; and encouraging compliance.
Collection fees only apply to the Collect and Pay service and are intended to provide both parents with an incentive to collaborate, and offset the cost of the scheme. Entry to the service is permitted if either both parents agree to it, or if the paying parent is deemed ‘unlikely to pay’. Paying parents therefore have the more influence in deciding which service type a case goes into.
The 20% collection fee for paying parents is a strong deterrent against non-compliance. The 4% collection fees for receiving parents acknowledges the costs associated with maintaining the case and provides a financial incentive for parents to consider using, or returning to, Direct Pay, or having a family-based arrangement, where appropriate.
The Government is dedicated to ensuring parents meet their obligations to children, taking robust enforcement action against those who do not.
Cases in Collect & Pay represent the most difficult cases, as many of these have been unwilling to pay voluntarily or have not been compliant in a Direct Pay arrangement. Cases where the paying parent has missed payments or demonstrated behaviour that suggests they are unlikely to pay, can be put on the Collect and Pay service. Fees only apply to the Collect and Pay Service. A fee of 20% is added to what the paying parent needs to pay, while 4% is deducted from maintenance paid to receiving parents. The receiving parent charge is only applied from the maintenance that the Child Maintenance Service has successfully collected.
Fees were introduced in 2014, partly with the objective to encourage greater collaboration and more family-based arrangements rather than using a statutory service.
After Collect and Pay fees were introduced an assessment was carried out by the previous government and published in The Child Maintenance Reforms; 30 Month Review of charging.
In July 2024 the government consulted on the proposal for wider reform to consolidate the CMS into a single service type where the CMS monitors and transfers payments. The consultation Improving the collection and transfer of payments, also proposed a new fee structure of just 2% for receiving parents, deducted from maintenance received; 2% for compliant paying parents, on top of maintenance owed; and 20% for non-compliant paying parents, on top of maintenance owed.
Following consideration of public responses concerning fees and other proposals in the consultation, and subsequent ministerial decisions, next steps will be detailed in the Government Response, which will be published in due course.
All parents are given the option to use the Direct Pay service, where no fees apply.
If a paying parent pays on time and in full on Direct Pay and there is no reason to believe they would be unlikely to pay; they cannot be forced to use the Collect and Pay service.
The 20% collection fee for paying parents is a deterrent against non-compliance and offsets the cost of action needed to recover arrears.
The Government is dedicated to ensuring parents meet their obligations to children, taking robust enforcement action against those who do not.
Cases in Collect & Pay represent the most difficult cases, as many of these have been unwilling to pay voluntarily or have not been compliant in a Direct Pay arrangement. Cases where the paying parent has missed payments or demonstrated behaviour that suggests they are unlikely to pay, can be put on the Collect & Pay service. Fees only apply to the Collect and Pay Service. A fee of 20% is added to what the paying parent needs to pay, while 4% is deducted from maintenance paid to receiving parents.
Fees were introduced in 2014, with the objectives of subsidising the cost of the service; encouraging greater collaboration and more family-based arrangements; and encouraging compliance.
When Collect and Pay charges were introduced, an assessment was carried out by the previous government and published in The Child Maintenance Reforms; 30 Month Review of charging. The government response to the assessment was that application fees may influence some parents’ decisions regarding their maintenance arrangement.
On 8 May 2024 the consultation Child Maintenance: Improving the collection and transfer of payments was published by the previous government before being extended on the 31 July by the current government. The consultation included a range of proposals with the key one being to remove the Direct Pay service and consolidate the CMS into a single streamlined service that monitors and transfers all payments. In addition, it also proposed a new fee structure of just 2% for receiving parents, deducted from maintenance received; 2% for compliant paying parents, on top of maintenance owed; and 20% for non-compliant paying parents, on top of maintenance owed.
Following consideration of public responses concerning fees and other proposals in the consultation, and subsequent ministerial decisions, next steps will be detailed in the Government Response, which will be published in due course.
It is for sponsoring employers to decide on what pension benefits they offer, provided they meet minimum standards. Scheme rules set out how the scheme should be run. It would not be appropriate for the Government to interfere in decisions made by individual schemes, beyond setting clear, affordable minimum standards that apply to all.
Pensions legislation does not usually apply new provisions retrospectively to rights that have already been accrued. It is generally seen to be unreasonable to add liabilities to pension schemes that could not have been taken into account in the funding assumptions that determined the contributions to be paid at the time. In some cases, the additional unplanned liabilities could result in significant additional contributions for the sponsoring employers, and ultimately threaten the future viability of some schemes.
It is extremely important to achieve a balance between providing members with some measure of protection against inflation and not increasing schemes’ costs beyond a level that schemes and employers can generally afford.
Analysis carried out by the Pensions Regulator estimates that, as of 31 March 2023, 23 per cent of private-sector occupational Defined Benefit (DB) pension schemes have no indexation applied to pre-1997 benefits. However, this is in addition to any Guaranteed Minimum Pension rights accrued between 1988 and 1997, which must be indexed by the scheme.
This information is published and available at: Data requests | The Pensions Regulator
Analysis by the Pensions Regulator estimates that, as of 31 March 2023, more than three quarters of schemes provide indexation on scheme benefits accrued before 6 April 1997. This is in addition to any Guaranteed Minimum Pension rights accrued between 1988 and 1997, which must be indexed by the scheme. These schemes represent over 80 per cent of the membership of private-sector occupational Defined Benefit (DB) pension schemes. This information is published and available at: Data requests | The Pensions Regulator
The Department does not hold any data on the financial status of the members of these schemes.
Analysis by the Pensions Regulator estimates that, as of 31 March 2023, more than three quarters of schemes provide indexation on scheme benefits accrued before 6 April 1997. This is in addition to any Guaranteed Minimum Pension rights accrued between 1988 and 1997, which must be indexed by the scheme. These schemes represent over 80 per cent of the membership of private-sector occupational Defined Benefit (DB) pension schemes. This information is published and available at: Data requests | The Pensions Regulator
The Department does not hold any data on the financial status of the members of these schemes.
The UK has a robust and flexible regime for protecting defined benefit (DB) pensions.
Sponsoring employers are ultimately responsible for meeting the promised pensions and DB pension schemes are subject to the statutory funding objective which requires them to have sufficient and appropriate assets to provide for their pension liabilities. Schemes must be valued, at least every three years, and where there is a funding deficit a recovery plan must be put in place, and the deficit filled as soon as the sponsor can reasonably afford.
The Pensions Regulator has a range of enforcement powers and can intervene to protect member benefits when needed.
Where an employer becomes insolvent, and the scheme winds up underfunded, benefits are underpinned by the Pension Protection Fund (PPF) which can provide compensation at 100% of scheme benefits for pensioner members and 90% of scheme benefits for deferred members.
I was the first Minister in 8 years to meet the WASPI campaign group and listen to their concerns.
We need time to review and consider the Ombudsman’s report along with the evidence provided during the investigation.
Once this work has been undertaken, the Government will be in a position to outline its approach.
The NHS Business Services Authority (NHSBSA) is only able to provide information on prescriptions for cannabis-based medicines that have been prescribed and submitted to the NHSBSA. Data on National Health Service prescriptions for unlicensed cannabis-based medicines is withheld in accordance with the UK General Data Protection Regulation, due to the number of prescriptions attributed to fewer than five patients, and the enhanced risk of the release of patient identifiable information. Patient information is not routinely collected for private prescriptions.
The following table shows the number of identifiable patients that were prescribed NHS prescriptions for licensed cannabis-based medicines, for instance epidyolex, nabilone, and sativex, in the community in England in the 12 months, from February 2024 to January 2025, the latest available data:
Total items prescribed to identified patients | Total number of unique identified patients |
5,413 | 880 |
Source: NHSBSA.
The Licence in Dental Surgery (LDS) exam is operated by the Royal College of Surgeons of England (RCSEng), and the exam is regulated by the General Dental Council (GDC). There are no restrictions to accessing the exam based on British residency status.
It is the role of the GDC to approve eligibility criteria for the exam, which is proposed by the RCSEng as its operator. The GDC is independent of the Government. The RCSEng continues to increase the capacity of the LDS exam to ensure more candidates can access a place.
The Licence in Dental Surgery (LDS) exam is operated by the Royal College of Surgeons of England (RCSEng), and the exam is regulated by the General Dental Council (GDC). There are no restrictions to accessing the exam based on British residency status.
It is the role of the GDC to approve eligibility criteria for the exam, which is proposed by the RCSEng as its operator. The GDC is independent of the Government. The RCSEng continues to increase the capacity of the LDS exam to ensure more candidates can access a place.
The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally.
The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market.
In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market.
In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports.
The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken.
The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally.
The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market.
In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market.
In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports.
The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken.
The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally.
The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market.
In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market.
In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports.
The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken.
It is very worrying that approximately 25% of 11 to 15-year-olds have tried vaping, despite the risks of nicotine addiction. Evidence suggests that vapes appeal to children because of the brightly coloured packaging, amongst other child-friendly features. Evidence also indicates that the nicotine content descriptions on vape packaging are not consistent between packaging, preventing adults from making informed decisions on nicotine strength.
The Tobacco and Vapes Bill provides my Rt Hon. Friend, the Secretary of State for Health and Social Care with regulation-making powers to introduce new requirements on retail packaging, including for vaping products and nicotine products. There is a balance to be struck between reducing the appeal of vapes to non-smokers, particularly children, whilst considering the implications for adult smokers to ensure we can achieve the greatest possible impact.
It is our intention to regulate the appeal of vapes to children, whilst minimising the impact on adult smokers. We plan on consulting on the preferred options to get this balance right as soon as possible after the bill gains Royal Assent.
The delivery of palliative and end of life care services is a devolved matter.
We have taken necessary decisions to fix the foundations in the public finances at the Autumn Budget, which enabled the Spending Review settlement of a £22.6 billion increase in resource spending for the Department from 2023/24 outturn to 2025/26. The employer National Insurance contributions rise will be implemented in April 2025.
In England, palliative care services are included in the list of services an integrated care board (ICB) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.
The delivery of palliative and end of life care services is a devolved matter.
We have taken necessary decisions to fix the foundations in the public finances at the Autumn Budget, which enabled the Spending Review settlement of a £22.6 billion increase in resource spending for the Department from 2023/24 outturn to 2025/26. The employer National Insurance contributions rise will be implemented in April 2025.
In England, palliative care services are included in the list of services an integrated care board (ICB) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.
The delivery of palliative and end of life care services is a devolved matter. We want to assure ourselves and the National Health Service in England that it has access to the workforce it needs in the years ahead to ensure that patients, including those at end of life, are cared for by the right professional, when and where they need it. We will need to do this in light of the 10-Year Health Plan.
In England, palliative and end of life care is wide-ranging, provided by generalist as well as specialist healthcare professionals, and is not disease/diagnosis specific. A large proportion of palliative and end of life care is not provided by palliative care specialists and, therefore, it is difficult to quantify the totality of the NHS workforce providing palliative and end of life care.
The Department has been working hard with industry to help resolve the shortages of radioisotopes, which are affecting the United Kingdom and other countries around the world. The affected radioisotopes are mainly used for diagnosing cancers, including prostate and breast cancer, and are also used for the imaging of organ function in scans, including for the heart. Supply of the affected molybdenum-technetium generators has improved significantly during week of 11 November.
The Department has worked in close partnership with National Health Service specialists from across the UK, suppliers, the British Nuclear Medicine Society, the UK Radiopharmacy Group, and the devolved administrations, including Scotland, to ensure that critical patients are prioritised, and that the limited supply is shared equitably between hospitals and trusts across the UK.
The Department issued a National Patient Safety alert which provided comprehensive management advice for NHS clinicians across the UK on how to manage and prioritise patients affected by these shortages. The guidance covers actions for health boards in the devolved nations, including on the coordination of mutual aid arrangements and escalation routes where issues are identified.
We have taken necessary decisions to fix the foundations in the public finances at the Autumn Budget, which has enabled the Spending Review settlement of a £22.6 billion increase in resource spending for the Department from 2023/24 outturn to 2025/26. The employer National Insurance rise will be implemented April 2025, and the Department will set out further details on the allocation of funding for next year in due course.
Primary care providers, including general practice (GP), dentistry, pharmacy, and eye care, are valued independent contractors who provide nearly £20 billion worth of National Health Services. Every year we consult with each sector both about what services they provide, and the money providers are entitled to in return under their contract. As in previous years, this issue will be dealt with as part of that process.
We will shortly begin discussions on the annual GP Contract and on the funding arrangements for community pharmacy in 2025/26. I am unable to say more until these have been concluded.
Whilst stock of a small number of medicines is held by the Government, for example as a result of COVID-19 preparedness, stockpiling essential medicines centrally is not a tool that the Department uses to limit the effects of production shortages. While we can’t always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they do arise, to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, including pharmacists, so they can advise and support their patients.
The Joint Committee on Vaccination and Immunisation (JCVI) recommended a universal varicella, also known as chickenpox, vaccination programme be introduced as part of the routine childhood schedule. This recommendation was based on an assessment of the estimated programme cost-effectiveness as well as cases of severe varicella that could be prevented. The JCVI’s statement is available at the following link:
Ministers have accepted the JCVI’s recommendation, and the Department is in discussions with NHS England and the UK Health Security Agency on the potential implementation of the recommendation.
The UK continues to call on Israel to increase humanitarian and commercial access into the Occupied Palestinian Territories by ensuring all aid crossings are fully operational, including the port of Ashdod. The Foreign Secretary recently spoke to Israeli Officials and raised the urgent need for a rapid increase in aid for those most in need. FCDO officials have raised the matter of this donation directly with the Israeli authorities and are working with colleagues in the Scottish Government to resolve the matter.
Inheritance tax is a wealth transfer tax charged on the estate (the property, money, and possessions) of someone who has died. In the latest available tax year (2021-22), 4.39% of all UK deaths were liable to inheritance tax.
The tax liability is on the estate and not the beneficiary of any inherited assets. As such, HMRC does not collect information on the beneficiaries of estates, as it has no reason to do so.
The Government announced several reforms to inheritance tax at Autumn Budget 2024. The Government’s analysis of these reforms is based on the number of estates expected to pay more inheritance tax. More information is available in the various policy papers published alongside the Budget: https://www.gov.uk/government/publications/autumn-budget-2024.
Inheritance tax is a wealth transfer tax charged on the estate (the property, money, and possessions) of someone who has died. In the latest available tax year (2021-22), 4.39% of all UK deaths were liable to inheritance tax.
The tax liability is on the estate and not the beneficiary of any inherited assets. As such, HMRC does not collect information on the beneficiaries of estates, as it has no reason to do so.
The Government announced several reforms to inheritance tax at Autumn Budget 2024. The Government’s analysis of these reforms is based on the number of estates expected to pay more inheritance tax. More information is available in the various policy papers published alongside the Budget: https://www.gov.uk/government/publications/autumn-budget-2024.
Small and medium sized businesses make a vital contribution to the UK economy. There are various arrangements in place that enable businesses to access reduced or zero import charges.
With regards to customs duty, the UK has a number of free trade agreements which enable businesses to benefit from paying reduced or zero customs duty. The UK also has several customs procedures which allow businesses to pay a reduced amount of duty on their imports, depending on what they are and what they do with them – for example, if they are importing them temporarily or repairing them.
VAT is due on all imports of goods into the UK at the same rate as domestic transactions. This ensures imports cannot undercut UK businesses and does not represent an additional charge for businesses buying imports. VAT registered businesses are able to reclaim VAT paid upon import, in the same way as for domestic purchases, as well as making use of VAT accounting schemes to smooth cash flow.
At £90,000, the UK has a higher VAT registration threshold than any EU country and the joint highest in the OECD. This keeps the majority of businesses out of the VAT regime altogether.
The Government’s approach to the VAT threshold and applicable rates aims to balance potential impacts on small businesses, including their growth and financial sustainability, the economy as a whole, and tax revenues. Tax breaks reduce the revenue available for public services and must represent value for money for the taxpayer.
The Government is committed to supporting disabled people and is determined that support should be focused on people who need it most. The aim of existing Vehicle Excise Duty (VED) exemptions for recipients of some disability benefits is to provide additional help for people who become disabled early, or relatively early, in life and as a result experience economic disadvantage. These allowances are therefore only available to people who become disabled before State Pension age.
For individuals who develop a disability after State Pension age, Attendance Allowance (AA) is a non-means-tested benefit which provides targeted help with the extra costs of disability and helps them maintain their independence. Unlike Disability Living Allowance and Personal Independence Payment, AA does not have a mobility component and is intended to cover the need for care or supervision an individual requires as a result of their disability rather than specific mobility needs. Individuals can however choose to use their AA to fund mobility aids.
While we have no current plans to reform the VED exemptions for recipients of some disability benefits, the Government keeps all taxes under review as part of the policy making process, and the Chancellor makes decisions at fiscal events in the context of the public finances.
The creative industries play a key role in driving economic growth. The Government is committed to supporting them as part of its plan to fix the foundations of the economy.
Orchestra Tax Relief (OTR) provides tax relief at a rate of 50% on production costs. To qualify for the relief, a concert must be performed by a group of at least 12 instrumentalists. Concerts with a vocal element, including a choir, may be eligible provided that the instrumentalists are the primary focus.
These rules help ensure OTR fulfils its objective of supporting and incentivising orchestra concerts specifically. The Government keeps the tax system under review and any changes will be announced at a fiscal event.
The Government is committed to breaking down barriers to opportunity, ensuring every child has access to high-quality education, which is why we have made the tough decision to end tax breaks for private schools. This will raise revenue for essential public services, including investing in the state education system
This VAT change will not impact pupils with most acute additional needs where these can only be met in private schools, as determined by an Education and Health Care Plan in England, and equivalent processes in other nations.
Where pupils are placed in a private school because their needs cannot be met in the state sector, and they have their places funded by their Local Authority, the Local Authority will be able to reclaim the VAT they incur on these pupils’ fees. In Northern Ireland, it will be the Education Authority who fund placements in private schools and will be able to reclaim the VAT in this way.
The government will publish a Tax Information and Impact Note setting out the impacts of the changes, including the equalities impacts, alongside the Finance Bill.
On 29 July, the Government announced that, as of 1 January 2025, all education services and vocational training provided by a private school in the UK for a charge will be subject to VAT at the standard rate of 20 per cent. This will also apply to boarding services provided by private schools.
The Government will confirm the introduction of these tax policy changes at the Budget on 30 October. Following scrutiny of the Government’s costing by the independent Office for Budget Responsibility, details of the Government’s assessment of the expected impacts of these policy changes will be published at the Budget in the usual way.
These changes will apply across the UK. The Barnett formula will continue to apply in the usual way as set out in the Statement of Funding Policy.
The Visit caseworker guidance provides guidance to decision makers when assessing Visitor applications. It sets out that all information provided by the applicant must be assessed which may include supporting statements or references provided by British nationals to support the application - Visit caseworker guidance (accessible) - GOV.UK
Visitor visa applications are assessed on their individual merits, considering all aspects of the case. This may include supporting documents provided by a sponsor, which are then evaluated, along with the rest of the application, against the balance of probabilities to determine if the application meets the requirements of the Visitor Immigration Rules - Immigration Rules - Immigration Rules Appendix V: Visitor - Guidance - GOV.UK.
At present, asylum seekers who have had their claim outstanding for 12 months or more, through no fault of their own, can apply for permission to work. Those permitted to work are restricted to jobs on the Immigration Salary List. This list is based on expert advice from the independent Migration Advisory Committee.
The Anti-Social Behaviour, Crime and Policing Act 2014 provides the police and local authorities with a range of flexible tools and powers that they can use to respond quickly and effectively to anti-social behaviour, including the misuse of fireworks.
To inform any future decisions on the legislative framework the Government will continue to engage with stakeholders to gather evidence on the issues raised by the antisocial use of fireworks, and consider any further steps that need to be taken to tackle the problem.
The Government is firmly committed to promoting and protecting the right to freedom of religion, or belief, and being a strong voice internationally in defence of this fundamental right.
Any attempt to intimidate, harass or harm individuals in the UK will not be tolerated. Wherever we identify such threats, we will use all measures, including through our world-class intelligence services, to mitigate risk to individuals.
Police forces are operationally independent of Government. Therefore, the Home Office does not comment on operational decisions taken by the Police, including, any decisions taken by the police to issue protective security advice.
The Blue Book of Protective Security is available to anyone who would like to improve their personal security, for whatever reason, and is freely available on the Protect UK website.Anyone who is concerned for their safety should contact the police in the first instance.
The Department is assessing current policies and identifying those which obstruct individuals from joining the Armed Forces. It is essential that new entrants to the Armed Forces are medically fit to meet the various challenges of Service life and the roles in which they will be expected to deploy.
Candidates with mild or moderate allergies are currently able to join the Armed Forces providing they meet certain criteria. Candidates with severe symptoms, including anaphylaxis and those who require an adrenaline auto-injector, are currently unable to join the Armed Forces as it is not possible to guarantee avoidance of allergen cross-contamination throughout a Service career, especially when on operations, or rapid access to life-saving treatment.
If an application is rejected on medical grounds, a candidate can appeal the decision with additional medical information. There is also an executive waiver process where the employing Service may, exceptionally, recruit someone who is below the normal entry standards.
The key objective of the government’s cladding funding schemes is to ensure that life safety fire risks associated with cladding are addressed as quickly as possible to ensure that residents in residential buildings are safe and feel safe in their homes. Funding is available towards eligible costs related to action needed to mitigate the risk posed by cladding on residential buildings over 11m in height. Commercial leaseholders operating in mixed use residential and commercial developments may in some circumstances benefit from protections against having to pay service charges towards equivalent works to fix cladding. Full details of eligibility for cladding safety funding can be found at Cladding Safety Scheme overview - GOV.UK.
The UK Government recognises the substantial contribution the Scottish tourism industry makes to the UK visitor economy. We are committed to working with industry to strengthen the future of this key sector.
While tourism is devolved, we work closely with the Scottish Government and its agencies to ensure that the sector thrives. This Government will also continue to encourage tourism across the whole of Scotland through our Brand Scotland work to promote Scotland around the world.